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Abstract
Background: It is believed that inflammatory bowel diseases (IBD) result from an imbalance in the intestinal
immune response towards the luminal microbiome. Dectin-1 is a widely expressed pattern recognition receptor
that recognizes fungi and upon recognition it mediates cytokine responses and skewing of the adaptive immune
system. Hence, dectin-1 may be involved in the pathogenesis of IBD.
Methods: We assessed the responses of dectin-1 deficient macrophages to the intestinal microbiota and
determined the course of acute DSS and chronic Helicobacter hepaticus induced colitis in dectin-1 deficient mice.
Results: We show that the mouse intestinal microbiota contains fungi and the cytokine responses towards this
microbiota were significantly reduced in dectin-1 deficient macrophages. However, in two different colitis models
no significant differences in the course of inflammation were found in dectin-1 deficient mice compared to wild
type mice.
Conclusions: Together our data suggest that, although at the immune cell level there is a difference in response
towards the intestinal flora in dectin-1 deficient macrophages, during intestinal inflammation this response seems
to be redundant since dectin-1 deficiency in mice does not affect intestinal inflammation in experimental colitis.
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Background
Pattern recognition receptors (PRR) are important for
host recognition of microorganisms. Various groups of
PRR are known which include the Toll-like receptors
(TLR), NOD-like receptors and C-type lectin-like recep-
tors (CLR). From many studies investigating TLR and
NLR receptor function in the intestine it became clear
that interaction between the intestinal microbiome and
PRRs expressed in the intestine is important in modify-
ing the intestinal immune system. TLRs and NLRs have
been shown to be involved in regulating epithelial bar-
rier function, secretion of antimicrobial peptides, IgA
production and secretion into the intestinal lumen, lym-
phoid tissue development and T cell function [1,2].
Furthermore, Myd88, several TLRs, NOD2 and NLPR3
deficient mice have all been shown to be more
susceptible to Dextran Sulphate Sodium (DSS) induced
colitis [3-9]. From patient studies it is clear that various
mutations in PRR are associated with IBD [10-13].
The current research on the host interactions with the
microbiota mainly focuses on the bacterial component,
however fungi are also present in the intestine [14], and
interact with pattern recognition receptors, mainly CLRs
like dectin-1, mannose receptor and DC-SIGN [15].
More than 55% of Crohn’s Disease (CD) patients make
antibodies against the mannan component of fungi com-
pared to only 8% of healthy individuals and antibody
titre is thought to be related to disease severity [16]. CD
patients also make antibodies against other fungal com-
ponents such as chitin and b-glucans [16,17]. Therefore
fungi and the PRR recognising them may play a role in
intestinal homeostasis.
CLRs are expressed in the intestine however, the
interaction between CLRs and the intestinal microbiota
is not well studied and in this paper we focus on dectin-
1. Dectin-1 binds b-glucans found on fungi and upon
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responses including TNF-a and IL-10 production
[18-21]. Co-stimulation of dectin-1 and TLR2-TLR6 has
been shown to increase stimulation for TNFa,I L - 1 2
and IL-2 production [19,20,22]. Dectin-1 has also been
shown to induce dendritic cell maturation and direct T
cell Th17 responses directly linking innate and adaptive
immunity [23,24]. However, little is known about the
role of dectin-1 in maintaining intestinal homeostasis.
Dectin-1 is highly expressed in the intestine [25] and
humans with CD have also been shown to have
increased numbers of dectin-1 expressing inflammatory
cells in the intestine compared with healthy individuals
[26]. Together this implies that dectin-1 may play a role
in intestinal immunity.
In order to establish the role of dectin-1 in intestinal
immunity we determined dectin-1 expression in mouse
colon and investigated responses towards the intestinal
microbiota by macrophages deficient in dectin-1.
Furthermore, we induced colitis in dectin-1 deficient
mice using DSS colitis and a Helicobacter hepaticus
induced colitis model to investigate the role of dectin-1
in intestinal inflammation.
Methods
Animals
Breeding colonies of C57BL/6 and C57BL/6 dectin-1
-/-
(A kind gift from Gordon D. Brown) mice were housed
and maintained under specific pathogen free conditions
in our animal facility at the Academic Medical Center
in Amsterdam. Animals were kept and handled in
accordance with the guidelines of the Animal Research
Ethics Committee of the University of Amsterdam.
Determination of fungi
1 gram of mouse faeces was dissolved in PBS and plated
on Sabouraud agar plates containing penicillin and gen-
tamicin. The colonies were identified using an Auxaco-
lor identification kit (Bio-rad).
Colitis experiments
Animals were sex-matched and between 8 and 12 weeks
of age at the time of study. For DSS colitis experiments
1,5% (w/v) DSS (TdB Consultancy, Uppsala, Sweden)
was added to the drinking water for 7 days. Body weight
was recorded daily, and weight loss on day 7 as com-
pared with day 0 was calculated. On day 7 of DSS
administration, animals were killed and organs collected.
The wet weight of spleen and colon was recorded
together with the total length of the colon. Colon weight
per 5 cm was used as a disease parameter.
For Helicobacter hepaticus induced colitis H. hepaticus
NCI-Frederick isolate 1A (strain 51449; American Type
Culture Collection) was grown and maintained as
previously described [27]. Mice were inoculated intra-
gastrically on days 0, 2, and 4 with 5 × 10
7-2 × 10
8 CFU
H. hepaticus. Anti-IL-10R monoclonal antibody was
produced and characterized as previously described [28].
Antibody treatment was commenced on the day of the
first inoculation with H. hepaticus, and mice received
weekly i.p. injections of 1 mg anti-IL-10R for the dura-
tion of the experiment. After 4 weeks animals were
killed and blood, spleen, liver, cecum and colon
collected.
Histochemistry
The longitudinally divided colons were rolled, fixed in
4% formalin and embedded in paraffin for routine his-
tology. An experienced pathologist evaluated formalin-
fixed haematoxylin tissue sections microscopically, in a
blinded fashion. Colons were evaluated, and graded
from 0 to 4 as an indication of incidence and severity of
inflammatory lesions based on the extent of the area
involved, the number of follicle aggregates, oedema,
fibrosis, hyperplasia, erosion/ulceration, crypt loss and
infiltration of granulocytes and mononuclear cells as
indicated in Table 1. The total inflammation score was
calculated as the average score of the above.
Immunohistochemistry
Frozen sections of mouse colon (10 μm) were processed
for immunohistochemistry as previously described [25].
Briefly, slides were ethanol fixed and blocked in 10%
normal rabbit serum for 10 min. The slides were
drained and incubated with purified mAb 2A11 or the
rat isotype control at 10 μg/ml for 2 h. Endogenous per-
oxidase was quenched using 0.3% H2O2 (Sigma-Aldrich
C o .L t d . ,S t .L o u i s ,M O )i n0 , 5 %n o r m a lr a b b i ts e r u m .
After washing in PBS, sections were incubated with bio-
tinylated mouse-adsorbed rabbit anti-rat IgG for 30 min.
After washing, slides were treated with the avidin-bio-
tin-complex (ABC)-horseradish peroxidase (HRP)
reagent for 30 min. followed by HRP substrate NovaRed
treatment. Slides were counterstained with haematoxylin
(Vector Laboratories), dehydrated with alcohol, cleared
with xylene, and mounted with microscopy Entellan
(Merck).
Fluorescent immunohistochemistry
Slides were acetone fixed and blocked in 10% normal
rabbit serum for 15 min. Slides were drained and incu-
bated with purified mAb 2A11 or the rat isotype control
at 10 μg/ml for 1 hour. After washing in PBS, sections
were incubated with Alexa 568 labelled goat anti rat IgG
(Molecular probes) for 1 hour. After washing sections
were incubated with FITC conjugated anti-mouse
CD11b for 1 hour. Slides where washed and mounted in
mounting medium containing DAPI (Vectashield).
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Page 2 of 10Measurements of colonic cytokines
Frozen colonic tissue was homogenized on ice in Green-
berger Lysis Buffer (150 mM NaCl, 15 mM Tris, 1 mM
MgCl·6H2O, 1 mM CaCl2, 1% Triton) with protease
inhibitor cocktail from Roche (11697498001), pH 7.4,
diluted 1:1 with PBS. Protein concentrations of IL-12,
IFNg,T N F a,I L - 1 0 ,M C P - 1a n dI L - 6w e r em e a s u r e di n
homogenates by cytometric bead array multiplex assay
(BD Biosciences, San Jose, CA, USA) or using ELISA
kits (R&D) according to manufacturer’s protocol.
Primary macrophage experiments
Thioglycollate-elicited peritoneal macrophages were iso-
lated 4 days after intraperitoneal injection of 1 ml 4% (w/
v) Brewer’s thioglycollate medium (BD). 2.5 × 10
5 pri-
mary macrophages were plated in 24 well tissue culture
plates with RPMI (Invitrogen) containing 50 IU/ml Peni-
cillin, 50 μl/ml streptomycin and 2 mM L-glutamine at
37°C in 5% CO2. After 2 hours, non-adherent cells were
removed by washing three times with medium. Diluted
cecum content, LPS or zymosan (Molecular Probes) were
added and incubated with the cells for 24 hours. Diluted
cecum content was produced by suspending the contents
of a mouse cecum in 50 ml PBS which was subsequently
filtered over a 40 um filter and frozen at -20°C and used
in a 1:1000 dilution. After 24 hours incubation no growth
of micro-organisms was found in the wells and no cell
death was observed by microscopic check for floating
cells. Cytokine levels were determined using ELISA kits
(R&D) according to manufacturer’s protocol.
Statistical analysis
All data are expressed as mean ± s.d. The statistical signifi-
cance of the differences was evaluated using an unpaired t-
test. Statistical significance was defined as P < 0.05.
Results
Dectin-1 localisation in mouse intestine
We started our investigation by confirming that dectin-1
is located in the large intestine of mice.
Immunohistochemical staining showed that dectin-1 is
expressed in the lamina propria of the mouse colon
(Figure 1A). As expected dectin-1 deficient mice did not
show staining for dectin-1 in the intestine (data not
shown). During DSS induced colitis the number of dec-
tin-1 expressing cells in WT animals increased dramati-
cally, suggesting an interaction with the intestinal
microbiota under inflammatory conditions (Figure 1A).
Fluorescent double staining showed that the main cells
expressing dectin-1 in the intestine where also positive
for CD11b i.e. macrophages, dendritic cells and neutro-
phils (Figure 1B).
Dectin-1 mediated cytokine responses towards intestinal
microbiota
To determine if dectin-1 is able to respond towards
fungal or food components in mouse faeces we used
WT thioglycollate-elicited peritoneal macrophages
which are known to express dectin-1 [29] and com-
pared their cytokine responses with those isolated
from dectin-1 deficient mice (Figure 1C and 1D). As a
positive control we incubated these cells with zymosan
(a b-glucan containing particle and known ligand for
dectin-1). Dectin-1 deficient macrophages showed a
50% reduction in both TNFa and IL-10 response after
24 hour incubation with zymosan. We also incubated
macrophages with bacterial components like LPS, LTA
and MDP which are not thought to interact with dec-
tin-1 and indeed there were no differences in TNFa
and IL-10 responses between WT and dectin-1 defi-
cient macrophages (Figure 1C and 1D) showing that
dectin-1 deficient macrophages were selectively defi-
cient in dectin-1 specific responses and developed nor-
mally. Diluted mouse faeces induced IL-10 (Figure 1C)
and TNFa (Figure 1D) production in WT macro-
phages. Faeces contains a whole array of various sti-
muli and our mouse faeces seems to contain
components that can induce a high IL-10 response but
does not stimulate TNFa production as much as
zymosan or LPS do.
Table 1 Colitis total inflammation score
score 0 1 2 3 4
Area involved 0% 1-10% 10-25% 25-50% > 50%
follicles Normal (0-1) Minimal (2-3) Mild (4-5) Moderate (6-7) Severe (> 7)
edema Absent Minimal Mild Moderate Severe
fibrosis Absent Minimal Mild Moderate Severe
Erosion/ulceration 0% 1-10% 10-25% 25-50% > 50%
Crypt loss 0% 1-10% 10-25% 25-50% > 50%
granulocytes Normal Minimal increase Mild increase Moderate increase Severe increase
Mononucl. cells Normal Minimal increase Mild increase Moderate increase Severe increase
The total inflammation score was determined by the average score of the following criteria: area involved, the number of follicle aggregates, oedema, fibrosis,
hyperplasia, erosion/ulceration, crypt loss and infiltration of granulocytes and mononuclear cells.
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Figure 1 Dectin-1 expression in colon and its involvement in macrophages activation after incubation with mouse faeces. A) Dectin-1
staining (Nova Red) of WT colon using 2A11 on frozen sections. Sections were counterstained with haematoxylin. Representative image of un-
inflamed tissue shows some dectin-1 expressing cells (arrows) in the mucosa. Representative image of inflamed colon after 7 days of DSS induce
colitis showing an increase in dectin-1 expressing cells. The antibodies seemed to stick more to the inflamed tissue as is shown with the isotype
control staining. B) Fluorescent immunohistochemistry showing DAPI, CD11b and dectin-1 staining of healthy intestine showing that dectin-1
expressing cells also express CD11b suggesting its macrophages, dendritic cells and neutrophils in the intestine that express dectin-1 (arrows).
TNFa (C) and IL-10 (D) protein concentrations were measured in the supernatants of thioglycollate elicited macrophages isolated from WT
C57BL/6 (white bars) or C57BL/6 dectin-1-/- (black bars) mice. Macrophages were incubated for 24 hours at 37°C with medium, zyomsan (0.5
particles/cell), LPS (100 ng/ml), LTA (5 ug/ml), MDP (10 ug/ml) or supernatants of mouse faeces. These data are representative of three
independent experiments done in duplicate, error bars indicate the SD. A t-test was used for statistical analysis. *, p < 0.05.
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Page 4 of 10IL-10 and TNFa responses depend on the combina-
tion of pattern recognition receptors that are triggered.
It has been shown that different bacteria are able to
induce completely different cytokine profiles and can
even work against each other [30,31]. The difference in
magnitude of IL-10 and TNFa induced by faeces com-
pared to zymosan is very likely due to different cell acti-
vation by the components, however a role for dectin-1
in the responses is clear in both stimuli since in dectin-
1-/- macrophages these cytokine responses were signifi-
cantly reduced, suggesting that dectin-1 deficient macro-
phages lack a response towards the fungal or food
components found in the mouse intestinal microbiota
(Figure 1C and 1D). The results shown are the response
towards WT faeces, the same results were found when
using dectin-1-/- faeces which suggests there are no dif-
ferences in the intestinal microbiota between these mice.
A yeast classified as one of the Rhodotorula species
was the only fungal component cultured consistently in
faeces of both dectin-1-/- and WT mice (data not
shown). Rhodotorula sp. can be found in faeces [32,33]
and are considered non pathogenic [34]. Rhodotorula sp.
are not considered to be medically important which
made it impossible for us to further determine the exact
species on our premises. Nonetheless these data show
that dectin-1 could be involved in responses towards the
fungal microbiota found in mouse intestine.
DSS induced colitis in dectin-1 deficient mice
Next, we tested the effect of dectin-1 deficiency in an
experimental model of DSS colitis. DSS is widely used
as an inducer of inflammation in the intestine. It causes
damage to the epithelial lining of the intestine which
increases the interaction of the microbiota with the
intestinal immune system, leading to an acute inflamma-
tion mainly involving innate immune cells [35]. Since
dectin-1 is expressed in the myeloid compartment of
the mouse intestine and is up-regulated during colitis
(Figure 1A and 1B) and the lack of dectin-1 leads to
reduced production of TNF-a and IL-10 production by
macrophages we hypothesised that dectin-1 deficient
mice would develop less inflammation after inducing
DSS colitis.
To test this we induced DSS colitis and after 7 days
mice lost 5-20% weight due to disease but no significant
differences were found in weight loss between dectin-1
deficient and WT mice (Figure 2A). No differences in
spleen weight were found (data not shown). Colon
weight, which is a measure of colon inflammation and
increases due to cell infiltration and oedema, did not
show significant differences between the two groups
either (Figure 2B). Histological scoring showed that both
WT and dectin-1 deficient mice had equal severe
inflammation in the intestine with crypt loss, crypt
erosion, ulceration, oedema and infiltration of both
monocytes and granulocytes. No significant differences
were found in these parameters in intestinal inflamma-
tion (Figure 2F). Representative pictures of healthy
colon, WT inflamed colon and dectin-1-/- inflamed
colon are shown in Figure 2C-D. We also analysed cyto-
kine levels in mouse colons and serum and were able to
measure TNF-a, MCP-1 and IL-10 in the colon lysates.
Colons of mice without induced inflammation did not
contain measurable cytokine levels (data not shown) and
no significant differences were found between the two
groups in inflamed colons (Figure 2G-I). Unexpectedly,
these data show that DSS colitis in dectin-1 deficient
mice develops the same as in WT mice.
Helicobacter hepaticus induced colitis in dectin-1 deficient
mice
Since DSS induced colitis did not show a role for dec-
tin-1 in intestinal inflammation we tested another colitis
model that is microbiota driven. H. hepaticus infected
C56BL6 mice that received I.P injections with anti-IL-10
receptor antibodies develop a chronic typhlocolitis over
the course of four weeks which is T cell dependent with
a mixed Th1/Th17 response [27]. The mechanisms
through which H. hepaticus is able to induce chronic
typhlocolitis are still unclear [36]. Results were variable
among different animals and no significant differences
were found in weight, spleen weight, colon and cecum
pathology (Figure 3A, B, F and 3G). Representative pic-
tures of healthy cecum, WT inflamed cecum and dec-
tin-1-/- inflamed cecum are shown in Figure 3C-E.
Levels of inflammatory cytokines were measured in
lysed colon and serum samples, only IL-10 and MCP-1
were above the detection limit in the lysed colon, but
no consistent or significant differences were found
between WT and dectin-1 deficient animals (Figure 3H
and 3I).
Discussion
The intestinal immune system is shaped by its interac-
tion with the microbiome and vice versa [1,37-39]. Dec-
tin-1 is a PRR able to influence innate and adaptive
immune responses upon recognition of fungi [40].
Indeed our in-vitro data show that faeces from our mice
are able to induce dectin-1 dependent cytokine
responses. Our data suggest that the luminal flora or
food components from our mice are able to interact
with dectin-1 and stimulate IL-10 and TNF-a produc-
tion by macrophages. Importantly however, our data
indicate that dectin-1, does not play a vital role in
experimental colitis in mice.
Crohn’s disease patients have been found to produce
antibodies against fungal glycocarbohydrates including
b-glucans and mannans [16,17]. C. albicans is a
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Figure 2 Dectin-1 involvement in DSS induced colitis. Mice were given 1.5% DSS in their drinking water for 7 days. A) Bodyweights were
measured as indication of disease severity in this model, weights are shown as percentage of weight on day seven compared to day one. B)
Colons were weighed as an indication of inflammation, shown as weight per 5 cm colon. F) Longitudinally divided colons were rolled, fixed and
embedded in paraffin for routine histology. Colons were evaluated by an experienced pathologist and graded from 0 to 4 points as indicated in
table 1. The total inflammation score was determined by the average score of the following criteria: area involved, the number of follicle
aggregates, oedema, fibrosis, hyperplasia, erosion/ulceration, crypt loss and infiltration of granulocytes and mononuclear cells. C) Representative
picture of healthy colon. D) Representative picture of WT colon after 7 days of DSS induced inflammation. E) Representative picture of dectin-
1-/- colon after 7 days of DSS induced inflammation. In inflamed colon a large amount of cell infiltration was found in both the mucosa and
submucosa (asterisk), areas of cryptloss were clear (arrow) and we also found gut associated lymphoid tissue (arrowheads). Bar, 200 um. G) TNFa
protein concentrations in colon lysates H) IL-10 protein concentrations in colon lysates I) MCP-1 protein concentrations in colon lysates. The
sample means are indicated with a line. A t-test was used for statistical analysis. *, p < 0.05, n = 10.
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Page 7 of 10suspected immunogen for these antibodies [41,42] and
as a major receptor for C. albicans [29,43], dectin-1 is
likely to be important in immune responses involving
patients with an intestinal C. albicans infection. Indeed,
C. albicans has been described to aggravate inflamma-
tion in DSS induced colitis [44]. However, mice are not
naturally infected with C. albicans a n dw ed i dn o tf i n d
Candida species in our mice. We found a fungus of the
Rhodutorula spp in the stools of our mice. Besides their
possible presence in faeces, these fungi are often found
in humid environments like bathrooms and soil and are
not considered to be pathogenic or play a role in colitis
[33].
We used two different colitis models to determine if
dectin-1 plays a role in the progression of intestinal
inflammation. When adding DSS to the drinking water
for 7 days, mice develop an acute inflammation which is
mainly driven by the innate immune system as T and B
cell deficient mice like RAG-/- and SCID animals also
develop colitis after feeding DSS [35,45]. The second
model we used was based on infection with H. hepaticus
in mice that received antibodies directed at the IL-10
receptor. In these mice inflammation develops over a
course of four weeks and both innate and adaptive
immune responses are involved in this chronic model of
colitis [28]. In both models, dectin-1 deficient mice did
not show any substantial or consistent differences in
weight, colon inflammation, systemic inflammation and
cytokine responses suggesting that the course of inflam-
mation is the same for WT and dectin-1-/- mice in
these models. This was surprising since in-vitro experi-
ments showed that dectin-1 deficiency had significant
effects on cytokine responses towards the mouse faeces
(Figure 1). It may be that during intestinal inflammation
other PRRs compensate for the lack of dectin-1; several
other receptors are known to recognise fungi including
TLRs [46,47], mannose receptor [29,48], dectin-2 [49]
and DC-SIGN [50] and its mouse homologue SIGN-R1
[51]. Since bacteria are the dominant bowel inhabitants
and only about 1% of the intestinal microbiome consists
of fungi [14], it may also be possible that dectin-1 invol-
vement in intestinal inflammation is overwhelmed by
responses towards the bacterial component.
Various PRR have been shown to play an important
role in human IBD and dectin-1 has been shown to
co-signal with TLR2 and TLR6 for the production of
various pro-inflammatory cytokines [19,20,22]. Clearly,
although our data suggest dectin-1 signalling is redun-
dant in intestinal inflammation TLR2 and/or TLR6
deficiency does affect experimental colitis via separate
mechanisms indicating that dectin-1 deficiency does
not seem to affect TLR signalling. This was also indi-
cated by our observation of normal responses to TLR
ligands other that dectin-1 in deficient cells. Indeed, a
mutation found in human dectin-1 which leads to par-
tial dectin-1 deletion has been shown not to be
involved in IBD [26]. It is likely that dectin-1 becomes
more relevant when the fungal burden in the intestine
increases, for instance due to antibiotic treatment or
infection.
Conclusions
Our in-vitro data suggest that dectin-1 is able to induce
a cytokine response towards mouse faeces, however dec-
t i n - 1d e f i c i e n c yi nm i c ed o e sn o ta f f e c tt h ec o u r s eo f
inflammation in two models of experimentally induced
colitis suggesting that dectin-1 signalling is redundant in
experimental colonic inflammation induced by either
DSS or H. hepaticus in mice.
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